Trial finds drug safe and effective in treating hepatitis C during pregnancy

Critics of the new recommendation to screen all pregnant women for hepatitis C—a lifelong infection that attacks the liver—argue that it’s wasteful to test for a disease among a population that can’t be treated, but results of a small phase I clinical trial at Magee-Womens Research Institute (MWRI) suggest otherwise: pregnancy could be an excellent time to diagnose and cure […]

» Read more

Alcohol abuse may raise risk of death in patients with abnormal heart rhythms

When patients under age 54 were hospitalized with abnormal heart rhythms, those who abused alcohol were 72% more likely to die before being discharged, according to preliminary research to be presented July 27-30, 2020, at the virtual American Heart Association’s Basic Cardiovascular Sciences 2020 Scientific Sessions. The meeting is a premier global exchange of the latest advances in basic cardiovascular […]

» Read more

A desk-based job may lower the risk of cognitive decline

A study suggests a sedentary job may provide better cognitive protection than a more physically active role. Experts have long warned about the potential dangers of a sedentary lifestyle. Many studies suggest that being physically inactive increases the risk of health issues. However, the connection between being physically active and maintaining cognitive health has been less clear. Now, a new […]

» Read more

Link between kidney dysfunction and premature births

Women with prepregnancy kidney dysfunction are at increased risk of preterm (premature) birth and other complications, especially women with chronic kidney disease, found new research published in CMAJ (Canadian Medical Association Journal). Preterm birth before 37 weeks’ gestation occurs in 6% to 11% of viable pregnancies and is the leading cause of infant death. “The timely recognition of prepregnancy kidney […]

» Read more

European Medicines Agency adopts positive opinion on monthly vaginal ring to reduce HIV risk

The International Partnership for Microbicides (IPM) today welcomed a positive opinion from the European Medicines Agency (EMA) on the dapivirine vaginal ring for use by cisgender women ages 18 and older in developing countries to reduce their risk of HIV-1 infection. The monthly ring is the first long-acting HIV prevention product, and is designed to address women’s unmet need for […]

» Read more
1 1,675 1,676 1,677 1,678 1,679 1,813